GENEDRIVE PLC Logo

GENEDRIVE PLC

Develops rapid, point-of-care pharmacogenetic testing platforms for personalized medicine.

GDR | IL

Overview

Corporate Details

ISIN(s):
GB00B1VKB244 (+2 more)
LEI:
213800ZYODIRZ87Y4K14
Country:
United Kingdom
Address:
THE INCUBATOR BUILDING, M13 9XX MANCHESTER

Description

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 10:10
New interactive investor hub
English 13.8 KB
2025-12-09 17:00
Agreement of Shareholder Loan
English 16.9 KB
2025-12-08 17:10
Annual Report and Accounts and date of AGM
English 13.1 KB
2025-12-05 08:20
Final Results
English 215.8 KB
2025-12-03 08:35
Notice of Results
English 13.7 KB
2025-12-01 16:30
Block Listing Returns
English 24.2 KB
2025-12-01 08:40
Results presented re. NHS CYP2C19 Genotype Testing
English 20.0 KB
2025-11-27 11:20
NHS implementation guide published for CYP2C19
English 16.9 KB
2025-11-26 08:25
Scotland national roll-out of MT-RNR1 ID Kit
English 15.3 KB
2025-11-19 08:25
Further re Shareholder Loan
English 17.3 KB
2025-11-04 08:30
MT-RNR1 ID Kit in Dublin’s Rotunda Hospital
English 14.8 KB
2025-10-31 08:00
Potential Shareholder Loan
English 13.2 KB
2025-10-24 17:30
Application for Listing & Total Voting Rights
English 12.6 KB
2025-10-10 14:32
Holding(s) in Company
English 52.5 KB
2025-10-10 14:31
Holding(s) in Company
English 23.9 KB

Automate Your Workflow. Get a real-time feed of all GENEDRIVE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENEDRIVE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENEDRIVE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Astria Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapies for allergic and immunologic diseases.
United States of America
ATXS
ATAI Life Sciences N.V. Logo
Develops psychedelic-inspired therapies for mental health disorders.
United States of America
ATAI
Atea Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing oral antiviral therapies for serious viral diseases.
United States of America
AVIR
Athira Pharma, Inc. Logo
Biopharma firm developing small molecule therapeutics for neurodegenerative diseases.
United States of America
ATHA
ATOSSA THERAPEUTICS, INC. Logo
Clinical-stage biopharmaceutical company developing oncology medicines for breast cancer.
United States of America
ATOS
aTYR PHARMA INC Logo
Develops medicines based on tRNA synthetase biology for fibrosis and inflammation.
United States of America
ATYR
Aura Biosciences, Inc. Logo
Develops Virus-Like Drug Conjugates as targeted therapies for solid tumors.
United States of America
AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharmaceutical company developing therapies for severe autoimmune diseases.
United States of America
AUPH
AURORA CANNABIS INC Logo
Global producer and distributor of cannabis for medical and recreational markets.
United States of America
ACB
Autolus Therapeutics plc Logo
Biopharmaceutical company developing programmed T cell therapies for cancer and autoimmune diseases.
United States of America
AUTL

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.